Cargando…

Associations between diabetes duration and self-stigma development in Japanese people with type 2 diabetes: a secondary analysis of cross-sectional data

OBJECTIVES: To examine the associations between self-stigma and diabetes duration in a sample of Japanese people with type 2 diabetes. DESIGN: A secondary analysis of a cross-sectional study. SETTING: Two university hospitals, one general hospital and one clinic in Tokyo, Japan. PARTICIPANTS: Outpat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Asuka, Fujimaki, Yuko, Fujimori, Shin, Isogawa, Akihiro, Onishi, Yukiko, Suzuki, Ryo, Ueki, Kohjiro, Yamauchi, Toshimasa, Kadowaki, Takashi, Hashimoto, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718458/
https://www.ncbi.nlm.nih.gov/pubmed/35380981
http://dx.doi.org/10.1136/bmjopen-2021-055013
_version_ 1784624730966327296
author Kato, Asuka
Fujimaki, Yuko
Fujimori, Shin
Isogawa, Akihiro
Onishi, Yukiko
Suzuki, Ryo
Ueki, Kohjiro
Yamauchi, Toshimasa
Kadowaki, Takashi
Hashimoto, Hideki
author_facet Kato, Asuka
Fujimaki, Yuko
Fujimori, Shin
Isogawa, Akihiro
Onishi, Yukiko
Suzuki, Ryo
Ueki, Kohjiro
Yamauchi, Toshimasa
Kadowaki, Takashi
Hashimoto, Hideki
author_sort Kato, Asuka
collection PubMed
description OBJECTIVES: To examine the associations between self-stigma and diabetes duration in a sample of Japanese people with type 2 diabetes. DESIGN: A secondary analysis of a cross-sectional study. SETTING: Two university hospitals, one general hospital and one clinic in Tokyo, Japan. PARTICIPANTS: Outpatients with type 2 diabetes aged 20–74 years and receiving treatment from diabetes specialist physicians (n=209) completed a self-administered questionnaire. PRIMARY AND SECONDARY OUTCOME MEASURES: Self-stigma was measured as the primary outcome. Patient Activation Measure, body mass index and haemoglobin A1c were measured as secondary outcomes. RESULTS: One-way analysis of covariance showed significant differences in self-stigma levels between the five groups of diabetes duration (≤5 years, 6–10 years, 11–15 years, 16–21 years and 22 years or more) after controlling for age, gender, education, marital status, diabetes treatment (insulin use) and diabetes-related complications, F(4,198)=2.83, p=0.026. Multiple comparisons using Bonferroni correction showed statistically significant differences in self-stigma levels between the groups with ≤5 years (95% CI 59.63 to 69.73) and 11–15 years with diabetes (95% CI 71.12 to 80.82; p=0.020). The highest mean level of self-stigma was observed in the group having diabetes for 11–15 years. CONCLUSIONS: Self-stigma was associated with diabetes duration and was lowest after diagnosis and gradually increased, with its highest levels being observed in those having diabetes for 11–15 years. Self-stigma takes time to develop and gradually increases in individuals as it is learnt through direct experiences of diabetes-related stigma after self-administering treatment in everyday social situations.
format Online
Article
Text
id pubmed-8718458
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-87184582022-01-12 Associations between diabetes duration and self-stigma development in Japanese people with type 2 diabetes: a secondary analysis of cross-sectional data Kato, Asuka Fujimaki, Yuko Fujimori, Shin Isogawa, Akihiro Onishi, Yukiko Suzuki, Ryo Ueki, Kohjiro Yamauchi, Toshimasa Kadowaki, Takashi Hashimoto, Hideki BMJ Open Diabetes and Endocrinology OBJECTIVES: To examine the associations between self-stigma and diabetes duration in a sample of Japanese people with type 2 diabetes. DESIGN: A secondary analysis of a cross-sectional study. SETTING: Two university hospitals, one general hospital and one clinic in Tokyo, Japan. PARTICIPANTS: Outpatients with type 2 diabetes aged 20–74 years and receiving treatment from diabetes specialist physicians (n=209) completed a self-administered questionnaire. PRIMARY AND SECONDARY OUTCOME MEASURES: Self-stigma was measured as the primary outcome. Patient Activation Measure, body mass index and haemoglobin A1c were measured as secondary outcomes. RESULTS: One-way analysis of covariance showed significant differences in self-stigma levels between the five groups of diabetes duration (≤5 years, 6–10 years, 11–15 years, 16–21 years and 22 years or more) after controlling for age, gender, education, marital status, diabetes treatment (insulin use) and diabetes-related complications, F(4,198)=2.83, p=0.026. Multiple comparisons using Bonferroni correction showed statistically significant differences in self-stigma levels between the groups with ≤5 years (95% CI 59.63 to 69.73) and 11–15 years with diabetes (95% CI 71.12 to 80.82; p=0.020). The highest mean level of self-stigma was observed in the group having diabetes for 11–15 years. CONCLUSIONS: Self-stigma was associated with diabetes duration and was lowest after diagnosis and gradually increased, with its highest levels being observed in those having diabetes for 11–15 years. Self-stigma takes time to develop and gradually increases in individuals as it is learnt through direct experiences of diabetes-related stigma after self-administering treatment in everyday social situations. BMJ Publishing Group 2021-12-30 /pmc/articles/PMC8718458/ /pubmed/35380981 http://dx.doi.org/10.1136/bmjopen-2021-055013 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Diabetes and Endocrinology
Kato, Asuka
Fujimaki, Yuko
Fujimori, Shin
Isogawa, Akihiro
Onishi, Yukiko
Suzuki, Ryo
Ueki, Kohjiro
Yamauchi, Toshimasa
Kadowaki, Takashi
Hashimoto, Hideki
Associations between diabetes duration and self-stigma development in Japanese people with type 2 diabetes: a secondary analysis of cross-sectional data
title Associations between diabetes duration and self-stigma development in Japanese people with type 2 diabetes: a secondary analysis of cross-sectional data
title_full Associations between diabetes duration and self-stigma development in Japanese people with type 2 diabetes: a secondary analysis of cross-sectional data
title_fullStr Associations between diabetes duration and self-stigma development in Japanese people with type 2 diabetes: a secondary analysis of cross-sectional data
title_full_unstemmed Associations between diabetes duration and self-stigma development in Japanese people with type 2 diabetes: a secondary analysis of cross-sectional data
title_short Associations between diabetes duration and self-stigma development in Japanese people with type 2 diabetes: a secondary analysis of cross-sectional data
title_sort associations between diabetes duration and self-stigma development in japanese people with type 2 diabetes: a secondary analysis of cross-sectional data
topic Diabetes and Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718458/
https://www.ncbi.nlm.nih.gov/pubmed/35380981
http://dx.doi.org/10.1136/bmjopen-2021-055013
work_keys_str_mv AT katoasuka associationsbetweendiabetesdurationandselfstigmadevelopmentinjapanesepeoplewithtype2diabetesasecondaryanalysisofcrosssectionaldata
AT fujimakiyuko associationsbetweendiabetesdurationandselfstigmadevelopmentinjapanesepeoplewithtype2diabetesasecondaryanalysisofcrosssectionaldata
AT fujimorishin associationsbetweendiabetesdurationandselfstigmadevelopmentinjapanesepeoplewithtype2diabetesasecondaryanalysisofcrosssectionaldata
AT isogawaakihiro associationsbetweendiabetesdurationandselfstigmadevelopmentinjapanesepeoplewithtype2diabetesasecondaryanalysisofcrosssectionaldata
AT onishiyukiko associationsbetweendiabetesdurationandselfstigmadevelopmentinjapanesepeoplewithtype2diabetesasecondaryanalysisofcrosssectionaldata
AT suzukiryo associationsbetweendiabetesdurationandselfstigmadevelopmentinjapanesepeoplewithtype2diabetesasecondaryanalysisofcrosssectionaldata
AT uekikohjiro associationsbetweendiabetesdurationandselfstigmadevelopmentinjapanesepeoplewithtype2diabetesasecondaryanalysisofcrosssectionaldata
AT yamauchitoshimasa associationsbetweendiabetesdurationandselfstigmadevelopmentinjapanesepeoplewithtype2diabetesasecondaryanalysisofcrosssectionaldata
AT kadowakitakashi associationsbetweendiabetesdurationandselfstigmadevelopmentinjapanesepeoplewithtype2diabetesasecondaryanalysisofcrosssectionaldata
AT hashimotohideki associationsbetweendiabetesdurationandselfstigmadevelopmentinjapanesepeoplewithtype2diabetesasecondaryanalysisofcrosssectionaldata